| 101 |
14522368 | The role of chemotherapy in brain metastases. | 2003 Oct |
1 |
| 102 |
14651727 | Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human. | 2003 Nov |
1 |
| 103 |
11808819 | Carbamazepine decreases antihypertensive effect of nilvadipine. | 2002 Jan |
1 |
| 104 |
11950784 | Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes. | 2002 May |
1 |
| 105 |
12007677 | Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot study. | 2002 Jun |
1 |
| 106 |
12008131 | LC determination of oxcarbazepine and its active metabolite in human serum. | 2002 May 15 |
1 |
| 107 |
12397847 | Pharmacokinetics of mood stabilizers and new anticonvulsants. | 2002 Winter |
1 |
| 108 |
12405865 | Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. | 2002 |
1 |
| 109 |
11158730 | Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A. | 2001 Feb |
1 |
| 110 |
11318771 | Carbamazepine is not a substrate for P-glycoprotein. | 2001 Apr |
4 |
| 111 |
11513246 | Carbamazepine: a 'blind' assessment of CVP-associated metabolism and interactions in human liver-derived in vitro systems. | 2001 Jun |
1 |
| 112 |
10771457 | The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers. | 2000 |
1 |
| 113 |
10772431 | Carbamazepine--indinavir interaction causes antiretroviral therapy failure. | 2000 Apr |
2 |
| 114 |
10907977 | Potential interaction between ritonavir and carbamazepine. | 2000 Jul |
1 |
| 115 |
10942191 | Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate. | 2000 Aug |
1 |
| 116 |
11020127 | Protease inhibitor-induced carbamazepine toxicity. | 2000 Jul-Aug |
1 |
| 117 |
10096433 | Metabolism of carbamazepine by CYP3A6: a model for in vitro drug interactions studies. | 1999 |
1 |
| 118 |
10217335 | Effects of carbamazepine coadministration on plasma concentrations of the enantiomers of mianserin and of its metabolites. | 1999 Apr |
1 |
| 119 |
10219967 | A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene in vitro. | 1999 Mar |
1 |
| 120 |
10354960 | Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs. | 1999 Jun |
2 |
| 121 |
10379423 | Metabolism and excretion of mood stabilizers and new anticonvulsants. | 1999 Aug |
2 |
| 122 |
10463320 | Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patients. | 1999 Jul |
2 |
| 123 |
10466905 | Potential fluconazole-induced carbamazepine toxicity. | 1999 Jul-Aug |
2 |
| 124 |
10486655 | [A new cause of resistant arterial hypertension: coprescription with anticonvulsant treatments]. | 1999 Aug |
1 |
| 125 |
10613614 | Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors. | 1999 Dec |
1 |
| 126 |
9521735 | Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites. | 1998 Mar 24 |
1 |
| 127 |
9536449 | Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam. | 1998 May |
1 |
| 128 |
9753209 | Effect of troglitazone on urinary excretion of 6beta-hydroxycortisol. | 1998 Sep |
1 |
| 129 |
9860152 | A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism. | 1998 Oct |
2 |
| 130 |
9084959 | Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations. | 1997 Mar |
1 |
| 131 |
9278208 | Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19. | 1997 Aug |
2 |
| 132 |
9314612 | Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation. | 1997 Sep |
2 |
| 133 |
9357097 | Elevation of plasma carbamazepine concentrations by ketoconazole in patients with epilepsy. | 1997 Oct |
1 |
| 134 |
9390105 | Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constants. | 1997 Nov |
2 |
| 135 |
8598183 | Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin. | 1996 Mar |
1 |
| 136 |
8610817 | Newer antidepressants and the cytochrome P450 system. | 1996 Mar |
1 |
| 137 |
8817061 | The use of transgenic cell lines for evaluating toxic metabolites of carbamazepine. | 1996 Jun |
2 |
| 138 |
8877250 | Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. | 1996 Sep |
1 |
| 139 |
8930576 | Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs. | 1996 Oct |
1 |
| 140 |
8968657 | Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors. | 1996 Dec |
1 |
| 141 |
8535412 | Induction of cytochrome P450 3A (CYP 3A) by E 5110, a non-steroidal anti-inflammatory agent (NSAID), and typical CYP 3A inducers in primary cultures of dog hepatocytes. | 1995 Aug |
1 |
| 142 |
8748427 | The emerging role of cytochrome P450 3A in psychopharmacology. | 1995 Dec |
3 |
| 143 |
8806399 | Cytochrome P450 isozymes and antiepileptic drug interactions. | 1995 |
1 |
| 144 |
7917777 | Lymphocyte microsomal epoxide hydrolase in patients on carbamazepine therapy. | 1994 Jun |
2 |
| 145 |
7974626 | Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service. | 1994 Aug |
1 |
| 146 |
8010982 | Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. | 1994 Jun 1 |
7 |